This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guglielmo, B J
Right arrow Articles by Gambertoglio, J G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guglielmo, B J
Right arrow Articles by Gambertoglio, J G

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 February; 31(2): 264-266

Pharmacokinetics of cefoperazone and tobramycin alone and in combination.

B J Guglielmo, J F Flaherty, T M Woods, G LaFollette and J G Gambertoglio

ABSTRACT

Certain beta-lactams have been shown to increase the clearance of tobramycin. We evaluated the pharmacokinetics of cefoperazone and tobramycin, alone and in combination, in healthy volunteers. No significant alteration in pharmacokinetic behavior was noted for cefoperazone or tobramycin alone or in combination.


Antimicrob Agents Chemother. 1987 February; 31(2): 264-266




This article has been cited by other articles:

  • Frei, C. R., Wiederhold, N. P., Burgess, D. S. (2008). Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulation. J Antimicrob Chemother 61: 621-628 [Abstract] [Full Text]